Johnson & Johnson : advances leadership in oncology innovation with more than 75 clinical study and real-world presentations at ASCO and EHA
Media contacts: Investor contact: ...
Source: marketscreener.com
📰 Cell Malignancies News
Cell Malignancies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Malignancies. Real-time updates on events, politics, business and more.
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Soci
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib (MK-1026) – as well as KEYTRUDA® (pembrolizumab) in multiple blood cancersRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Ca...
Source: pharmiweb.com
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual Meeting
01.12.2022 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from clinical trials and real-world studies at the upcoming 64th American Society of Hematology (ASH) Annual Meeting from Dec. ...
United States Statement Of Merck Co Inc Exchange Commission Merck Co Inc Convention Center Selected Merck
Source: wallstreet-online.de